COL3A1
Collagen alpha-1(III) chain
Also known as: CO3A1_HUMAN, EDS4A
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P02461
- Gene
- COL3A1
- Ensembl
- ENSG00000168542
- Chromosome
- 2
- Canonical length
- 1466 aa
- Protein class
- Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins
- Subcellular location
- Endoplasmic reticulum
- Secretome location
- Secreted to extracellular matrix
OverviewNCBI Gene
This gene encodes the pro-alpha1 chains of type III collagen, a fibrillar collagen that is found in extensible connective tissues such as skin, lung, uterus, intestine and the vascular system, frequently in association with type I collagen. Mutations in this gene are associated with Ehlers-Danlos syndrome type IV, and with aortic and arterial aneurysms. [provided by R. Dalgleish, Feb 2008]
Canonical amino-acid sequenceUniProt
1466 residues, UniProt reviewed canonical sequence.
>P02461|COL3A1
1 MMSFVQKGSW LLLALLHPTI ILAQQEAVEG GCSHLGQSYA DRDVWKPEPC QICVCDSGSV
61 LCDDIICDDQ ELDCPNPEIP FGECCAVCPQ PPTAPTRPPN GQGPQGPKGD PGPPGIPGRN
121 GDPGIPGQPG SPGSPGPPGI CESCPTGPQN YSPQYDSYDV KSGVAVGGLA GYPGPAGPPG
181 PPGPPGTSGH PGSPGSPGYQ GPPGEPGQAG PSGPPGPPGA IGPSGPAGKD GESGRPGRPG
241 ERGLPGPPGI KGPAGIPGFP GMKGHRGFDG RNGEKGETGA PGLKGENGLP GENGAPGPMG
301 PRGAPGERGR PGLPGAAGAR GNDGARGSDG QPGPPGPPGT AGFPGSPGAK GEVGPAGSPG
361 SNGAPGQRGE PGPQGHAGAQ GPPGPPGING SPGGKGEMGP AGIPGAPGLM GARGPPGPAG
421 ANGAPGLRGG AGEPGKNGAK GEPGPRGERG EAGIPGVPGA KGEDGKDGSP GEPGANGLPG
481 AAGERGAPGF RGPAGPNGIP GEKGPAGERG APGPAGPRGA AGEPGRDGVP GGPGMRGMPG
541 SPGGPGSDGK PGPPGSQGES GRPGPPGPSG PRGQPGVMGF PGPKGNDGAP GKNGERGGPG
601 GPGPQGPPGK NGETGPQGPP GPTGPGGDKG DTGPPGPQGL QGLPGTGGPP GENGKPGEPG
661 PKGDAGAPGA PGGKGDAGAP GERGPPGLAG APGLRGGAGP PGPEGGKGAA GPPGPPGAAG
721 TPGLQGMPGE RGGLGSPGPK GDKGEPGGPG ADGVPGKDGP RGPTGPIGPP GPAGQPGDKG
781 EGGAPGLPGI AGPRGSPGER GETGPPGPAG FPGAPGQNGE PGGKGERGAP GEKGEGGPPG
841 VAGPPGGSGP AGPPGPQGVK GERGSPGGPG AAGFPGARGL PGPPGSNGNP GPPGPSGSPG
901 KDGPPGPAGN TGAPGSPGVS GPKGDAGQPG EKGSPGAQGP PGAPGPLGIA GITGARGLAG
961 PPGMPGPRGS PGPQGVKGES GKPGANGLSG ERGPPGPQGL PGLAGTAGEP GRDGNPGSDG
1021 LPGRDGSPGG KGDRGENGSP GAPGAPGHPG PPGPVGPAGK SGDRGESGPA GPAGAPGPAG
1081 SRGAPGPQGP RGDKGETGER GAAGIKGHRG FPGNPGAPGS PGPAGQQGAI GSPGPAGPRG
1141 PVGPSGPPGK DGTSGHPGPI GPPGPRGNRG ERGSEGSPGH PGQPGPPGPP GAPGPCCGGV
1201 GAAAIAGIGG EKAGGFAPYY GDEPMDFKIN TDEIMTSLKS VNGQIESLIS PDGSRKNPAR
1261 NCRDLKFCHP ELKSGEYWVD PNQGCKLDAI KVFCNMETGE TCISANPLNV PRKHWWTDSS
1321 AEKKHVWFGE SMDGGFQFSY GNPELPEDVL DVHLAFLRLL SSRASQNITY HCKNSIAYMD
1381 QASGNVKKAL KLMGSNEGEF KAEGNSKFTY TVLEDGCTKH TGEWSKTVFE YRTRKAVRLP
1441 IVDIAPYDIG GPDQEFGVDV GPVCFLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against COL3A1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.66
- Highest tissue expression
- 2,222 nTPM
Expression across tissuesHPA
Tissue
- cervix: 2,222 nTPM
- smooth muscle: 1,998 nTPM
- gallbladder: 1,957 nTPM
- placenta: 1,861 nTPM
- urinary bladder: 1,026 nTPM
- ovary: 748 nTPM
Single-cell type
- hepatic stellate cells: 3,789 nCPM
- endometrial stromal cells: 2,717 nCPM
- fibroblasts: 1,545 nCPM
- decidual stromal cells: 783 nCPM
- pericytes: 575 nCPM
- fibro-adipogenic progenitors: 480 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- choroid plexus: 23 nTPM
- thalamus: 23 nTPM
- cerebral cortex: 22 nTPM
- white matter: 8.8 nTPM
- basal ganglia: 3.5 nTPM
- pons: 3.5 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about COL3A1.
Disease | AllUniProt
Conditions COL3A1 is implicated in, by any mechanism.
- Ehlers-Danlos syndrome, vascular type (EDSVASC) MIM:130050
- Polymicrogyria with or without vascular-type Ehlers-Danlos syndrome (PMGEDSV) MIM:618343
Disease | GeneticClinVar
946 pathogenic / likely-pathogenic of 3,942 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Ehlers-Danlos syndrome, type 4
- Familial thoracic aortic aneurysm and aortic dissection
- Polymicrogyria with or without vascular-type Ehlers-Danlos syndrome
- Familial aortopathy
- COL3A1-related disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.1
- gnomAD pLI
- 1
- gnomAD missense Z
- 4.09
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- aorta smooth muscle tissue morphogenesis
- basement membrane organization
- cell-matrix adhesion
- cellular response to amino acid stimulus
- cerebral cortex development
- chondrocyte differentiation
- collagen fibril organization
- digestive tract development
- elastic fiber assembly
- endochondral bone morphogenesis
- fibroblast proliferation
- heart development
- in utero embryonic development
- integrin-mediated signaling pathway
- layer formation in cerebral cortex
- limb joint morphogenesis
- lung development
- multicellular organism growth
- negative regulation of immune response
- negative regulation of neuron migration
- neuron migration
- peptide cross-linking
- platelet activation
- positive regulation of Rho protein signal transduction
- response to angiotensin
- response to cytokine
- response to radiation
- skin development
- supramolecular fiber organization
- tissue homeostasis
- transforming growth factor beta receptor signaling pathway
- transforming growth factor beta1 production
- wound healing
Molecular functions
- extracellular matrix structural constituent
- extracellular matrix structural constituent conferring tensile strength
- integrin binding
- metal ion binding
- platelet-derived growth factor binding
- protease binding
- SMAD binding
Cellular components
- endoplasmic reticulum lumen
- extracellular matrix
- extracellular region
- extracellular space
- collagen type III trimer
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of COL3A1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads COL3A1 as an antibody target. Whether an autoantibody or antibody against COL3A1 could matter depends on whether native COL3A1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
COL3A1 is annotated as secreted, so native COL3A1 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label COL3A1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...